Your browser doesn't support javascript.
loading
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.
Borde, Julika; Ernst, Corinna; Wappenschmidt, Barbara; Niederacher, Dieter; Weber-Lassalle, Konstantin; Schmidt, Gunnar; Hauke, Jan; Quante, Anne S; Weber-Lassalle, Nana; Horváth, Judit; Pohl-Rescigno, Esther; Arnold, Norbert; Rump, Andreas; Gehrig, Andrea; Hentschel, Julia; Faust, Ulrike; Dutrannoy, Véronique; Meindl, Alfons; Kuzyakova, Maria; Wang-Gohrke, Shan; Weber, Bernhard H F; Sutter, Christian; Volk, Alexander E; Giannakopoulou, Olga; Lee, Andrew; Engel, Christoph; Schmidt, Marjanka K; Antoniou, Antonis C; Schmutzler, Rita K; Kuchenbaecker, Karoline; Hahnen, Eric.
Afiliação
  • Borde J; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Ernst C; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Niederacher D; Department of Gynecology and Obstetrics, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Weber-Lassalle K; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Schmidt G; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Hauke J; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Quante AS; Department of Gynecology and Obstetrics, Technical University Munich, University Hospital Rechts der Isar, Munich, Germany.
  • Weber-Lassalle N; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Horváth J; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Pohl-Rescigno E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Arnold N; Institute of Clinical Molecular Biology, Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Rump A; Institute for Clinical Genetics, Technische Universitaet Dresden, Dresden, Germany.
  • Gehrig A; Institute of Human Genetics, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Hentschel J; Institute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig, Germany.
  • Faust U; Institute of Medical Genetics and Applied Genomics, University Hospital Tuebingen, Tuebingen, Germany.
  • Dutrannoy V; Institute of Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Meindl A; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, University Hospital Munich, Munich, Germany.
  • Kuzyakova M; Institute of Human Genetics, University Medical Center, Georg August University, Goettingen, Germany.
  • Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Weber BHF; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
  • Sutter C; Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany.
  • Volk AE; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Giannakopoulou O; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lee A; Division of Psychiatry, University College London, London, UK.
  • Engel C; UCL Genetics Institute, University College London, London, UK.
  • Schmidt MK; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Antoniou AC; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Schmutzler RK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kuchenbaecker K; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
J Natl Cancer Inst ; 113(7): 893-899, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33372680
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha